Pamela J. Cramer, Chief Human Resources Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 27,190 shares at $58.36 ($1.6M) on 2025-04-08, disclosed to the SEC on 2025-04-10.
Scheduled sale ($1.6M) by Chief Human Resources Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.36 | 6,430 | $375K | 23.1% |
| 2 | $58.36 | 6,430 | $375K | 23.1% |
| 3 | $59.00 | 600 | $35K | 2.2% |
| 4 | $60.00 | 6,700 | $402K | 24.8% |
| 5 | $62.00 | 7,030 | $436K | 26.8% |
| Total | $59.72 avg | 27,190 |
| $1.6M |
| 100% |
| Filing → |
| RYTM | SELL | 2025-11-12 | $4.2M | — | Filing → |
| RYTM | SELL | 2025-07-29 | $261K | — | Filing → |
| RYTM | SELL | 2025-07-11 | $2.1M | — | Filing → |